Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Assaf C Bester

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Plos One|February 19, 2009
Impaired replication stress response in cells from immunodeficiency patients carrying Cernunnos/XLF mutationsMichal Schwartz, Yifat S Oren, Assaf C Bester, et al.
ACS Bio & Med Chem Au|June 22, 2026
Encapsulation of Exosomal Volatile Organic Compounds for Modulating the NF-κB Pathway in MonocytesDina Hashoul, Rand Shibel, Haya Dahamshy-Silawi, et al.
Cell|May 3, 2011
Nucleotide deficiency promotes genomic instability in early stages of cancer developmentAssaf C Bester, Maayan Roniger, Yifat S Oren, et al.
Journal of Biomedical Science|February 28, 2024
Integration of transcription regulation and functional genomic data reveals lncRNA SNHG6's role in hematopoietic differentiation and leukemiaJoshua M Hazan, Raziel Amador, Tahleel Ali-Nasser, et al.
EMBO Molecular Medicine|April 8, 2014
The unfolded protein response affects readthrough of premature termination codonsYifat S Oren, Michelle L McClure, Steven M Rowe, et al.
Cell|April 21, 2018
An Integrated Genome-wide CRISPRa Approach to Functionalize lncRNAs in Drug ResistanceAssaf C Bester, Jonathan D Lee, Alejandro Chavez, et al.
Science (New York, N.Y.)|May 18, 2019
Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathwayYu-Ru Lee, Ming Chen, Jonathan D Lee, et al.
Nature Genetics|October 2, 2019
Germline NPM1 mutations lead to altered rRNA 2'-O-methylation and cause dyskeratosis congenitaDaphna Nachmani, Anne H Bothmer, Silvia Grisendi, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Plos One|February 19, 2009
Impaired replication stress response in cells from immunodeficiency patients carrying Cernunnos/XLF mutationsMichal Schwartz, Yifat S Oren, Assaf C Bester, et al.
ACS Bio & Med Chem Au|June 22, 2026
Encapsulation of Exosomal Volatile Organic Compounds for Modulating the NF-κB Pathway in MonocytesDina Hashoul, Rand Shibel, Haya Dahamshy-Silawi, et al.
Cell|May 3, 2011
Nucleotide deficiency promotes genomic instability in early stages of cancer developmentAssaf C Bester, Maayan Roniger, Yifat S Oren, et al.
Journal of Biomedical Science|February 28, 2024
Integration of transcription regulation and functional genomic data reveals lncRNA SNHG6's role in hematopoietic differentiation and leukemiaJoshua M Hazan, Raziel Amador, Tahleel Ali-Nasser, et al.
EMBO Molecular Medicine|April 8, 2014
The unfolded protein response affects readthrough of premature termination codonsYifat S Oren, Michelle L McClure, Steven M Rowe, et al.
Cell|April 21, 2018
An Integrated Genome-wide CRISPRa Approach to Functionalize lncRNAs in Drug ResistanceAssaf C Bester, Jonathan D Lee, Alejandro Chavez, et al.
Science (New York, N.Y.)|May 18, 2019
Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathwayYu-Ru Lee, Ming Chen, Jonathan D Lee, et al.
Nature Genetics|October 2, 2019
Germline NPM1 mutations lead to altered rRNA 2'-O-methylation and cause dyskeratosis congenitaDaphna Nachmani, Anne H Bothmer, Silvia Grisendi, et al.
Pageof 2